Back to search
FDAFDA · Food and drugs·Recall number Z-2650-2014

Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.

Published September 24, 2014 · Recall initiated: July 18, 2014

Summary

FDA records medical device Class III recall Z-2650-2014, published September 24, 2014 and initiated July 18, 2014. Recalling firm: Diagnostica Stago, Inc.; Status: Terminated; Reported quantity: 514 kits; Lot: 510(k) #K111822, Lot #112366, Part # REF 00311US. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Diagnostica Stago, Inc.
Distributor
Distributed USA (nationwide) and the country of Canada.
Lot
510(k) #K111822, Lot #112366, Part # REF 00311US
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate. recalled?

Yes. FDA published recall Z-2650-2014 on September 24, 2014. Reported hazard: Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers.

What should I do if I have this product?

Voluntary: Firm initiated · Letter